Patent Assignment
Reel/Frame 021215/0595
Assignment of Assignor's Interest
Recorded: 2008-07-09
Pages: 7
Assignors
EMLEN, WOODRUFF
Executed: 2008-07-02
HOLERS, V. MICHAEL
Executed: 2008-07-02
FLYNN, PETER
Executed: 2008-06-18
Assignee
TALIGEN THERAPEUTICS, INC.
12635 EAST MONTVIEW BOULEVARD, SUITE 223, AURORA, COLORADO, 80045
Covered Property
(1)
Humaneered Anti-Factor B Antibody
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Dec 12, 2012
From: TALIGEN THERAPEUTICS, INC.
To: ALEXION CAMBRIDGE CORPORATION
Reel/Frame 029454/0515 →
Change of Address
Feb 12, 2013
From: ALEXION CAMBRIDGE CORPORATION
To: ALEXION CAMBRIDGE CORPORATION
Reel/Frame 029801/0586 →
Merger
Jun 19, 2015
From: ALEXION CAMBRIDGE CORPORATION
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 035866/0477 →
Confirmatory License
Jan 26, 2018
From: UNIVERSITY OF COLORADO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045169/0549 →